Source: Annual Congress 2005 - Physiotherapy techniques: from evaluation to rehabilitation
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
V. N. Martchenko, M. D. Didour, E. V. Pavlova, E. V. Gvozdev (St. Petersburg, Russian Federation). Influence of non-medicamentous methods of treatment on heart rate variability (HRV) at patients with bronchial asthma (BA). Eur Respir J 2005; 26: Suppl. 49, 1182

Member's Comments

No comment yet.

Related content which might interest you: Changes of heart rate variability in different types of breathing in patients with bronchial asthma (BA) Source: Eur Respir J 2001; 18: Suppl. 33, 34s Year: 2001 Influence of resistance training on heart rate variability in the difficult-to-control asthmatic patients. Source: Virtual Congress 2020 – Novel insights into exercise training Year: 2020 Efficacy and safety of salmeterol in patients with bronchial asthma (BA) and ischemic heart disease (IHD) Source: Eur Respir J 2002; 20: Suppl. 38, 57s Year: 2002 Efficacy of adaptative servo-ventilation (ASV) versus continuous positive airway pressure (CPAP) in treatment of cheyne-stokes respiration (CSR) in heart failure (HF) patients Source: Annual Congress 2004 - CPAP therapy for OSA Year: 2004 Low levels of nasal continuous positive airway pressure (CPAP) treatment in patients with congestive heart failure (CHF) and Cheyne-Stokes respiration (CSR) Source: Eur Respir J 2001; 18: Suppl. 33, 505s Year: 2001 Comparison of the acute effects of salbutamol and terbutaline on heart rate variability in adult asthmatic patients Source: Eur Respir J 2001; 17: 863-867 Year: 2001 Dose-dependent effects of salbutamol (S) and fenoterol (F) in patients with bronchial asthma (BA) and ischaemic heart disease (IHD) Source: Eur Respir J 2001; 18: Suppl. 33, 47s Year: 2001 A comparison of clinical characteristics between cough variant asthma (CVA) and bronchial asthma (BA) in adult patients Source: Annual Congress 2010 - Asthma aspect of diagnosis and criteria for follow-up Year: 2010 Heart rate variability (HRV) and blood pressure (BP) changes in patients with neuromuscular disease (NMD) following setup of non-invasive ventilation (NIV) Source: Annual Congress 2013 –The heart of the matter: sleep disordered breathing Year: 2013 Impact of bisphosphonate (BP) use on lung function decline and treatment response in patients (pts) with idiopathic pulmonary fibrosis (IPF) Source: Virtual Congress 2020 – News on diagnosis and therapy of idiopathic pulmonary fibrosis Year: 2020 Reduced heart rate variability in chronic bronchial asthma with steroid dependency Source: Eur Respir J 2004; 24: Suppl. 48, 508s Year: 2004 Pulse wave velocity (PWV) in patients (pts) with moderate COPD and cardiovascular risk: The effect of an inhaled long-acting β2-agonist/corticosteroid (SUMMIT) Source: International Congress 2016 – Novel insights into the treatment of COPD Year: 2016 Comparison between presence of respiratory symptoms and peak expiratory flow (PEF) values <80% predicted as screening tools for obstructive airways diseases (OAD) Source: Annual Congress 2011 - Monitoring with lung function tests in airway diseases Year: 2011 Effect of short-acting bronchodilators (BDs) on the severity of respiratory muscle (RM) strength in COPD patients (pts) Source: Annual Congress 2013 –COPD treatment Year: 2013 Effects of a physical training protocol on heart rate kinetics and heart rate variability indexes in patients with pulmonary arterial hypertension. Source: International Congress 2019 – Exercise and rehabilitation in patients with acute and chronic respiratory diseases Year: 2019 Respiratory training as a method of psychological rahabilitation for bronchial asthma (BA) patients Source: Eur Respir J 2005; 26: Suppl. 49, 311s Year: 2005 Indacaterol/glycopyrronium (IND/GLY) reduces exacerbation and improves lung function versus salmeterol/fluticasone (SFC) in patients with and without prior ICS use: The FLAME study Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations Year: 2016 The influence of inhalation device for bronchodilators on the results of therapy in primary care patients with bronchial asthma (BA) and chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Asthma control or asthma severity Year: 2008 Correlation between heart rate variability indexes and aerobic physiological variables in patients with COPD Source: Annual Congress 2013 –Exercise, physiotherapy techniques and assessment methods in COPD and asthma Year: 2013 Nocturnal oxygen therapy (NOT) versus nasal ventilation with Auto-CS in patients with severe chronic heart failure (CHF) and Cheyne-Stokes respiration (CSR): a long-term study over 2 years Source: Eur Respir J 2002; 20: Suppl. 38, 9s Year: 2002